SynbiCITE Centre
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2013
- Initiating Organization: Imperial College - London
- Initiator Type: Academia
- No disease focus
- Location: Europe
Abstract
Synthetic Biology Innovation Commercial and Industrial Translation Engine (SynbiCITE) is a pioneering Innovation and Knowledge Centre (IKC) dedicated to promoting the adoption and use of synthetic biology by industry. The IKC is an internationally recognized lead center in industrializing synthetic biology research, giving the U.K. a globally renowned national resource of interacting partners from across the U.K.’s leading academic institutions, industry, and business.
Mission
SynbiCITE is focused at Imperial College London and is accelerating the commercialization of world-class science and the emerging technologies encompassed by synthetic biology into new products, tools, processes, and services.
The overall aim is to grow U.K. industry in the sector and improve synthetic biology, using industry to achieve significant economic impact, generate wealth for the companies, generate skilled workers, and create jobs. This will, in turn, show the value of public investment in synthetic biology through economic growth and the societal and environmental advantages resulting from the technology development in the U.K.
SynbiCITE and partners across the U.K. and globally are committed to developing this technology through responsible innovation, which encompasses ethical, societal, and environmental considerations.
Impact/Accomplishment
SynbiCITE offers several training programs including LEAP (Synthetic Biology Leadership Excellence Accelerator Program), Lean Launchpad for Synthetic Biology, Three Day MBA: Developing entrepreneurship in synthetic biology, DNA synthesis and tools, and Project Management for Biotech.
See http://synbicite.com/training/
Links/Social Media Feed
|
Homepage |
Points of Contact
SynbiCITE
Imperial College Incubator
Level 1 Bessemer Building
Imperial College London
London SW7 2AZ
CEO
Stephen Chambers
phone: +44 (0)20 7594 5910
phone: +44 (0)7518 404 104 (mobile)
Commercial Director
John Collins
phone: +44 (0)20 7594 5800
phone: +44 (0)7876 750 624 (mobile)
Sponsors & Partners
|
Aberystwyth University |
|
Agilent Technologies UK Ltd. |
|
Algenuity |
|
Algipharma AS |
|
Bangor University |
|
Biosyntha Technologies Ltd. |
|
Cardiff University |
|
Chain Biotech |
|
Committed Capital Financial Services Ltd. |
|
Defence Science and Technology Laboratory |
|
DR Reddy’s Laboratories (EU) Ltd. |
|
Fujifilm Diosynth Biotechnologies (UK) Ltd. |
|
GlaxoSmithKline R&D Ltd. |
|
Green Biologics Ltd. |
|
Hockley International Ltd. |
|
Imperial College London |
|
Ingenza Ltd. |
|
Kings College London |
|
LabGenius |
|
Lisk & Jones Consultants Ltd. |
|
Lonza Biologics PLC |
|
Microsoft Research Ltd. |
|
Morph BioInformatics Ltd. |
|
New Generation Biogas (NGB) Ltd. |
|
Newcastle University |
|
New-Food Innovation |
|
Oil Plus Ltd. |
|
Oxitec Ltd. |
|
OxSyBio Ltd. |
|
Procter & Gamble Technical Centres Ltd. |
|
Prokarium Ltd. |
|
Pulse Medical Technologies Ltd. |
|
Queen’s University of Belfast |
|
Royal College of Art |
|
Shell Global Solutions UK |
|
Sphere Fluidics Ltd. |
|
Suterra UK |
|
Swansea University |
|
Syngenta Ltd. |
|
Synpromics Ltd. |
|
Synthace Ltd. |
|
University College London |
|
University of Birmingham |
|
University of Bristol |
|
University of Cambridge |
|
University of Edinburgh |
|
University of Exeter |
|
University of Glasgow |
|
University of Oxford |
|
University of Sheffield |
|
Visbion Ltd. |
|
Warwick University |